| Bioactivity | Fosinopril Sodium is the ester prodrug of an angiotensin-converting enzyme (ACE) inhibitor, used for the treatment of hypertension and some types of chronic heart failure. |
| Invitro | Fosinopril (0, 1, 10, 33, 100μM; 30 min) partially inhibits the cosedimentation of liposomes and recombinant LPLA2[1].Fosinopril (250 nM) shows no inhibition of the soluble esterase activity of LPLA2[1].Fosinopril (0.372, 0.744, 1.116 μM) displays a non-competitive inhibition effect on ACE activity with a Ki value of 1.675 μM[2]. |
| Name | Fosinopril sodium |
| CAS | 88889-14-9 |
| Formula | C30H45NNaO7P |
| Molar Mass | 585.64 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | 4°C, sealed storage, away from moisture *In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture) |
Fosinopril sodium
CAS: 88889-14-9 F: C30H45NNaO7P W: 585.64
Fosinopril Sodium is the ester prodrug of an angiotensin-converting enzyme (ACE) inhibitor, used for the treatment of hy
Data collection：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.